Low dose cytosine-arabinoside has only minimal differentiation inducing capacity in HL60 cells
- 1 November 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (11) , 1561-1569
- https://doi.org/10.1016/0277-5379(89)90298-8
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukaemiaScandinavian Journal of Haematology, 2009
- Quantitative enzyme determination; a parameter for leukemic cell differentiationLeukemia Research, 1987
- Low dose cytosine arabinoside in acute myeloid leukemia: Remission is not due to differentiation inductionAmerican Journal of Hematology, 1985
- Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemiaLeukemia Research, 1984
- Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?Blood, 1983
- Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemiaLeukemia Research, 1983
- An ultraviolet spectrophotometric assay for α-naphthyl acetate and α-naphthyl butyrate esterasesAnalytical Biochemistry, 1981
- DIFFERENTIATION OF MYELOID LEUKAEMIC CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1979
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977
- Early responses to chemotherapy detected by pulse cytophotometryBritish Journal of Cancer, 1976